Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [(177)Lu]Lu-PSMA I&T

SIMPLE SUMMARY: Radioligand therapy (RLT) with prostate-specific membrane antigen (PSMA)-directed agents has shown remarkable results in patients with advanced prostate cancer. Our objective was to provide data on the side effect profile of PSMA-directed RLT using the therapeutic radiotracer [(177)L...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartrampf, Philipp E., Weinzierl, Franz-Xaver, Serfling, Sebastian E., Pomper, Martin G., Rowe, Steven P., Higuchi, Takahiro, Seitz, Anna Katharina, Kübler, Hubert, Buck, Andreas K., Werner, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833540/
https://www.ncbi.nlm.nih.gov/pubmed/35158913
http://dx.doi.org/10.3390/cancers14030647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833540/
https://www.ncbi.nlm.nih.gov/pubmed/35158913
http://dx.doi.org/10.3390/cancers14030647

Ejemplares similares